Adjuvant engineering for cancer immunotherapy : development of a synthetic TLR2 ligand with alternative functions
スポンサーリンク
概要
- 論文の詳細を見る
- 2011-03-01
著者
-
Akazawa Takashi
Deparetment Of Molecular Genetics Institute Osaka Medical Center For Cancer And Cardiovascular Disea
-
Inoue Norimitsu
Deparetment Of Molecular Genetics Institute Osaka Medical Center For Cancer And Cardiovascular Disea
関連論文
- Innate Immune Therapy with a Bacillus Calmette-Guerin Cell Wall Skeleton After Radical Surgery for Non-Small Cell Lung Cancer : A Case-Control Study
- The expression of a novel natural killer inhibitory molecule, Cho-1, on the chorionic cytotrophoblast cells of successful pregnancy, but not of spontaneous abortion
- A Novel Negative Regulator Molecule, Cho-1, Is Involved in the Cytotoxicity by Human Natural Killer Cells but Not in Cytotoxic T Lymphocytes
- The cytoplasmic 'linker region' in Toll-like receptor 3 controls receptor localization and signaling
- Induction of NKG2D ligands on human dendritic cells by TLR ligand stimulation and RNA virus infection
- NK-activating dendritic cells are elicited by stimulation with Toll-like receptor 3
- Adjuvant engineering for cancer immunotherapy : Development of a synthetic TLR2 ligand with increased cell adhesion
- Reversible force transduction in tendrils of Passiflora coerulea
- Enhancement of antitumor natural killer cell activation by orally administered Spirulina extract in mice
- Molecular cloning of a pig homologue of membrane cofactor protein (CD46)
- Biosynthesis and excretion of hydrolases in germinating cereal seeds
- Relationship Between Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria
- Adjuvant engineering for cancer immunotherapy : development of a synthetic TLR2 ligand with alternative functions
- Molecular Genetics of Paroxysmal Nocturnal Hemoglobinuria